Drugs / MRrhTSH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00454220 | Jul 2007 → Jul 2011 | multinodular goiter | Genzyme, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MRrhTSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00454220 ↗ |
| Modality | Protein / enzyme biologic | “Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH)” NCT00454220 ↗ |